New Developmental Pattern of Lesions in Alcohol - Related Adult - Type Self - Healing Cutaneous Mucinosis: A Short Report and Review of the Literatures

article information

Journal of Skin and Stem Cell: Vol.3, issue 4; e67022
published online: December 31, 2016
article type: Case Report
received: October 21, 2016
revised: November 29, 2016
accepted: December 15, 2016
DOI: https://doi.org/10.5812/jssc.67022
Crossmark

New Developmental Pattern of Lesions in Alcohol - Related Adult - Type Self - Healing Cutaneous Mucinosis: A Short Report and Review of the Literatures

authors:

avatar Najmolsadat Atefi 1 , avatar Elham Behrangi 1 , avatar Azadeh Goodarzi 1 , avatar Nasrin Shayanfar 1 , avatar Sedighe Naeji 1 , * , avatar Maryam Nokandeh 1 , avatar Mahba Azizi 1 , avatar Parvaneh Hassani 2 , avatar Zahra Azizian 3

Dermatology Department, Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
Islamic Azad University, Tehran Medical Sciences Branch, Tehran, Iran
Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran

how to cite: Atefi N, Behrangi E, Goodarzi A, Shayanfar N, Naeji S, et al. New Developmental Pattern of Lesions in Alcohol - Related Adult - Type Self - Healing Cutaneous Mucinosis: A Short Report and Review of the Literatures. J Skin Stem Cell. 2016;3(4):e67022. https://doi.org/10.5812/jssc.67022.

Abstract

Self - healing juvenile cutaneous mucinosis (SHJCM) is an extremely rare disorder that manifests by sudden onset papules and nodules in juvenile patients that primarily affects the face and peri - articular areas. There are a few reports (less than 20 cases) of Self - healing juvenile cutaneous mucinosis (SHJCM), especially self - healing adult - type cutaneous mucinosis (less than 5 cases). This report presents an alcoholic 23 - year - old male with hard nodular mucinous lesions that was progressively converted to the soft papular type. To the best of the author’s knowledge an d based on the literature, this is a new pattern of mucinous lesions in conjunction with alcohol consumption, as a new probable triggering factor. Due to the self - limiting nature of this disorder, the diagnosis should be kept in the physician’s mind to prevent unnecessary diagnostic or aggressive therapeutic approaches in acute onset cutaneous mucinous.

1. Introduction

Self - healing juvenile cutaneous mucinosis (SHJCM) is a rare disease in dermatology, characterized by sudden onset of papules and nodules located primarily on the face and peri - articular areas of juvenile patients (1). It was described by Colomb (2) and Bonerandi (3) and in the 2 following decades, many other similar cases have been reported (4-12). Cutaneous mucinosis has various clinical types, such as SHJCM and congenital forms (13). In previous studies, different types of SHJCM, such as the nodular type (14-16), focal type (6, 17), familial type (10), recurrent type (18) with different lesion site presentation (1, 15), have been report. Proper approach to this disorder and its mimickers have been presented (3, 19, 20). Rarely, there has been recognized cases of self - healing cutaneous mucinosis in adult patients (18, 21, 22). The association between self - healing cutaneous mucinosis and underlying disorders, like nephroblastoma and epilepsy, has been proposed (5, 21). Approximately 20 case studies have been written about SHJCM (14, 23). The current patient had 3 major clinical presentations of cutaneous mucinosis, including nodular and papular lesions, and periorbital edema. Hard nodular lesions are slowly converted to the superficial soft papular lesions after alcohol cessation. The current report describes a new developmental pattern of cutaneous mucinosis lesions in an adult patient during a 3 - year follow - up with alcohol consumption as one of the probable underlying associations or triggering factors in the setting of self - healing cutaneous mucinosis.

2. Case Presentation

A 23 - year - old male referred with 2 months history of changes in facial shape and severe itching of the body, in June, 2014. An early skin examination revealed 2 types of cutaneous lesions in addition to periorbital swelling: hard asymptomatic nodules located around large joints like the knee, elbows, and wrist. Face (bridge of the nose, forehead, and temples), back, and flanks were also involved (Figures 1 and 2). The second lesions were numerous, extremely pruritus, 2 to 3 mm, firm and waxy, closely spaced papules, which were locally distributed. The most common sites of involvement were the scalp, upper trunk, and fingers. The overlaying skin was shiny, hyperpigmented, and indurated (Figure 3).

Multiple Hard Nodules Located in the Periarticular Area Around the Wrist
Multiple Hard Nodules Located in the Periarticular Area Around the Wrist
Figure 1.

Multiple Hard Nodules Located in the Periarticular Area Around the Wrist

Multiple Hard Nodules Located in the Periarticular Area Around the Knee
Multiple Hard Nodules Located in the Periarticular Area Around the Knee
Figure 2.

Multiple Hard Nodules Located in the Periarticular Area Around the Knee

Ivory White Papular Skin Lesions with Hyperpigmented and Indurated Skin Overlaying It on the Upper Back
Ivory White Papular Skin Lesions with Hyperpigmented and Indurated Skin Overlaying It on the Upper Back
Figure 3.

Ivory White Papular Skin Lesions with Hyperpigmented and Indurated Skin Overlaying It on the Upper Back

Hair loss in the affected area of the scalp was prominent (Figure 4). Systemic examination was normal. He had a history of alcohol consumption before skin lesions. A punch biopsy was performed from a papular lesion as well as a deep excisional biopsy from a nodular lesion of the forearm.

Hair Loss in Affected Areas of the Scalp
Hair Loss in Affected Areas of the Scalp
Figure 4.

Hair Loss in Affected Areas of the Scalp

Histopathologic features of the papular lesion revealed focal epidermal parakeratosis and accumulation of mucinous material in the upper and mid portion of the dermis, and also a mild increase in fibroblast cells (Figure 5). Nodular lesion in pathologic examination showed multiple areas of mucin deposition in deep dermis and increased number of fibroblast cells with ganglion - like features (Figure 6). Atypia and mitoses were not found. Mild perivascular infiltration of chronic inflammatory cells was also evident. The deposited material in the 2 samples were positively stained by alcian blue at pH 2.5 for mucin and stained negatively for amyloid on congo - red stain (Figure 7).

Hematoxylin & Eosin Staining Shows Accumulation of Mucinous Material in the Upper & Mid Dermis with a Mild Increase in Fibroblasts
Hematoxylin & Eosin Staining Shows Accumulation of Mucinous Material in the Upper & Mid Dermis with a Mild Increase in Fibroblasts
Figure 5.

Hematoxylin & Eosin Staining Shows Accumulation of Mucinous Material in the Upper & Mid Dermis with a Mild Increase in Fibroblasts

Deep Dermis Shows Multiple Areas of Mucin Deposition Associated with Increased Fibroblasts; Some with Ganglion - Like Features
Deep Dermis Shows Multiple Areas of Mucin Deposition Associated with Increased Fibroblasts; Some with Ganglion - Like Features
Figure 6.

Deep Dermis Shows Multiple Areas of Mucin Deposition Associated with Increased Fibroblasts; Some with Ganglion - Like Features

The Deposited Material at Deep Dermis in the Two Samples Was Positive for Mucin on Alcian Blue Staining at pH 2.5
The Deposited Material at Deep Dermis in the Two Samples Was Positive for Mucin on Alcian Blue Staining at pH 2.5
Figure 7.

The Deposited Material at Deep Dermis in the Two Samples Was Positive for Mucin on Alcian Blue Staining at pH 2.5

To rule out probable underling disorders associated with mucinosis, a baseline lab evaluation was conducted. A complete blood count, liver and renal function tests, thyroid stimulating hormone, serology of viral hepatitis, HIV, serum and urine protein electrophoresis, erythrocyte sedimentation rate, C - reactive protein, antinuclear antibodies and X - ray of the wrist (for the rule out calcium deposition disorders) were done with all results being normal.

Based on clinical features and histopathologic study, diagnosis of cutaneous mucinosis was confirmed. At first, Isotretinoin 20 mg daily was prescribed for the patient yet the therapy was interrupted after 3 weeks due to drug side effects. The patient was visited 3 months later. In the follow - up sessions, new nodular lesions were developing on his back yet not on the other areas. The newly formed lesions were more superficial and smaller than previous lesions. Old papular lesions disappeared gradually. After 2 years, in May 2016, all skin lesions were completely healed without any therapy. It should be noted that the patient stopped alcohol consumption prior to improvement.

3. Discussion

Self - healing cutaneous mucinosis is a rare disorder, which commonly appears in younger patients as the juvenile type (from 13 months to 15 years old), yet it could appear at any age (rarely after 20 years old as the reported case) (18, 20-22, 24). The skin manifestations are mainly characterized by sudden onset of asymptomatic papules and nodules on different cutaneous locations; mostly on the face, peri - articular areas, and the abdomen (15). One of the main unique features of SHJCM is complete resolution within weeks to months, although in some cases, the course may be longer (16).

Another interesting feature of this disorder is an association with extra - cutaneous manifestations, such as peripheral painful polyarthritis or signs of connective tissue disorders or autoimmune disease; thus some previous reports have recommended conducting antinuclear antibodies and complete blood cell counts in those with evidence of these accompanying associations (25). In most cases, the predominant histopathologic features are edema of the papillary and reticular dermis along with collagen bundles separation (due to mucin deposition), slightly increased number of fibroblast cells, and a mild perivascular infiltrate. Various reports of different histopathological features of SHJCM have been evident. In a report by Wadee et al. (5), mucin deposition in the mid and deep portion of reticular dermis, arborizing thin - walled vessels, and prominent spindle - shaped fibroblasts were exhibited. Cowen et al. (26) reported fibroblast cells in stellate, spindled shape, rhabdoid or strap - like figures. It seems that the differentiation of SHJCM from proliferative fasciitis/nodular fasciitis is critical (8). Despite various histological features, the diagnosis of SHJCM is mainly based on clinical presentations like sudden onset of papules and nodules located primarily on the face and peri - articular areas, which may disappear without any special treatment. As a rule, SHJCM may be differentiated from other forms of cutaneous mucinosis by some specific characteristics, including its early age of onset, the lack of systemic symptoms, spontaneous resolution, and the absence of dysglobulinemia or thyroid dysfunction (9). Until now, the nature of the disorder has remained unclear. It has been suggested that the ethological source of the disorder may be altered fibroblast cells function, which is triggered by viral infections or immune reactions (19).

In the current case, lesions developed after alcohol consumption and healed once stopped, so alcohol could be considered as a new triggering factor. The most prominent clinical feature of the current patient was slow conversion of hard nodular lesions to the superficial soft papular lesions. There were not any systemic disturbances or viral infection to be considered as a source of the disease onset. As shown in other cases, SHJCM may not require any therapeutic interventions due to its self - limiting nature (3, 19, 27-29).

Although there are various successful therapeutic modalities for cutaneous mucinosis (30-35) yet in probable cases of self - healing cutaneous mucinosis, the physician should prevent unnecessary diagnostic tests or aggressive therapies.

References

  • 1.

    Nagaraj LV, Fangman W, White WL, Woosley JT, Prose N, Selim MA, et al. Self-healing juvenile cutaneous mucinosis: cases highlighting subcutaneous/fascial involvement. J Am Acad Dermatol. 2006;55(6):1036-43. [PubMed ID: 17110219]. https://doi.org/10.1016/j.jaad.2006.06.024.

  • 2.

    Colomb D, Racouchot J, Vittori F. Mucinouse d'evolution regressive sans paraproteine chez une jeune fille. Lyon Med. 1973;230:474-5.

  • 3.

    Bonerandi JJ, Andrac L, Follana J, Moreau S, Aubert L. [Self-healing juvenile cutaneous mucinosis. Clinical, histological and ultrastructural study (author's transl)]. Ann Dermatol Venereol. 1980;107(1-2):51-7. [PubMed ID: 7369658].

  • 4.

    Rongioletti F, Rebora A. [Cutaneous mucinosis]. Ann Dermatol Venereol. 1993;120(1):75-87. [PubMed ID: 8338331].

  • 5.

    Wadee S, Roode H, Schulz EJ. Self-healing juvenile cutaneous mucinosis in a patient with nephroblastoma. Clin Exp Dermatol. 1994;19(1):90-3. [PubMed ID: 8313651].

  • 6.

    Cannata G, Gambini C, Ciaccio M. Self-healing localized cutaneous mucinosis. Dermatology. 1994;189(1):93-4. [PubMed ID: 8003801]. https://doi.org/10.1159/000246796.

  • 7.

    Kim YJ, Kim YT, Kim JH. Self-healing juvenile cutaneous mucinosis. J Am Acad Dermatol. 1994;31(5 Pt 1):815-6. [PubMed ID: 7929936].

  • 8.

    Caputo R, Grimalt R, Gelmetti C. Self-healing juvenile cutaneous mucinosis. Arch Dermatol. 1995;131(4):459-61. [PubMed ID: 7726590].

  • 9.

    de las Heras ME, Perez B, Arrazola JM, Rocamora A, Ledo A. Self-healing cutaneous mucinosis. Dermatology. 1996;192(3):268-70. [PubMed ID: 8726646]. https://doi.org/10.1159/000246382.

  • 10.

    Gonzalez-Ensenat MA, Vicente MA, Castella N, Vila J, Arimany J. Self-healing infantile familial cutaneous mucinosis. Pediatr Dermatol. 1997;14(6):460-2. [PubMed ID: 9436845].

  • 11.

    Velho GC, Oliveira M, Alves R, Silvestre F, Massa A, Baptista AP. Childhood cutaneous mucinosis. J Eur Acad Dermatol Venereol. 1998;10(2):164-6. [PubMed ID: 9553916].

  • 12.

    Aydingoz IE, Candan I, Dervent B. Self-healing juvenile cutaneous mucinosis. Dermatology. 1999;199(1):57-9. [PubMed ID: 10449960]. https://doi.org/10.1159/000018180.

  • 13.

    Chen CW, Tsai TF, Chang SP, Chen YF, Hung CM. Congenital cutaneous mucinosis with spontaneous regression: an atypical cutaneous mucinosis of infancy? Clin Exp Dermatol. 2009;34(7):804-7. [PubMed ID: 19077089]. https://doi.org/10.1111/j.1365-2230.2008.03000.x.

  • 14.

    Barreau M, Dompmartin-Blanchere A, Jamous R, Chababi M, Soutou B, Reynier-Rezzi J, et al. Nodular lesions of self-healing juvenile cutaneous mucinosis: a pitfall!. Am J Dermatopathol. 2012;34(7):699-705. [PubMed ID: 22481495]. https://doi.org/10.1097/DAD.0b013e3182459345.

  • 15.

    Abbas O, Saleh Z, Kurban M, Al-Sadoon N, Ghosn S. Asymptomatic papules and nodules on forehead and limbs. Self-healing juvenile cutaneous mucinosis (SHJCM). Clin Exp Dermatol. 2010;35(3):76-8. [PubMed ID: 20500191]. https://doi.org/10.1111/j.1365-2230.2009.03504.x.

  • 16.

    Nanda A, Selim MK, Al-Sabah H, Singhal V, Kapila K. Self-healing juvenile cutaneous mucinosis manifesting with subcutaneous nodules. Indian J Dermatol Venereol Leprol. 2010;76(2):198-9. [PubMed ID: 20228561]. https://doi.org/10.4103/0378-6323.60567.

  • 17.

    Nebrida ML, Tay YK. Cutaneous focal mucinosis: a case report. Pediatr Dermatol. 2002;19(1):33-5. [PubMed ID: 11860567].

  • 18.

    Jang KA, Han MH, Choi JH, Sung KJ, Moon KC, Koh JK. Recurrent self-healing cutaneous mucinosis in an adult. Br J Dermatol. 2000;143(3):650-1. [PubMed ID: 10971350].

  • 19.

    Kofler H, Lipsker D, Maurer H, Burgdorf W, Requena L, Torrelo A, et al. Self-healing juvenile cutaneous mucinosis: challenging diagnosis and management. J Dtsch Dermatol Ges. 2014;12(9):815-7. [PubMed ID: 25176461]. https://doi.org/10.1111/ddg.12379.

  • 20.

    Williams CA, Merkel KL. A mimic of self-healing juvenile cutaneous mucinosis? Pediatr Dermatol. 2014;31(6):140-4. [PubMed ID: 25233809]. https://doi.org/10.1111/pde.12426.

  • 21.

    Yaghoobi R, Bagherzade A, Aliabdi M, Kheradmand P, Kazerouni A, Feily A. Adult Variant of Self-healing Cutaneous Mucinosis in a Patient with Epilepsy. Acta Med Indones. 2016;48(1):58-62. [PubMed ID: 27241546].

  • 22.

    Kalkan G, Akbay G, Eksioglu, M, Astarci, M. Self-healing Cutaneous Mucinosis in an Adult. J Turk Acad Dermatol. 2013;7(2). https://doi.org/10.6003/jtad.1372c4.

  • 23.

    Wriston CC, Rubin AI, Martin LK, Kossard S, Murrell DF. Plaque-like cutaneous mucinosis: case report and literature review. Am J Dermatopathol. 2012;34(4):50-4. [PubMed ID: 22617136]. https://doi.org/10.1097/DAD.0b013e3181f87e91.

  • 24.

    Steffes WE, Bezalel SA, Church AA, Vincek V, Wesson SK. A case of self-healing juvenile cutaneous mucinosis. Dermatol Online J. 2015;21(6). [PubMed ID: 26158364].

  • 25.

    White WL, Prose NS, Morrell DS. Self-healing juvenile cutaneous mucinosis. Arch Dermatol. 2009;145(2):211-2. [PubMed ID: 19221280]. https://doi.org/10.1001/archdermatol.2008.599.

  • 26.

    Cowen EW, Scott GA, Mercurio MG. Self-healing juvenile cutaneous mucinosis. J Am Acad Dermatol. 2004;50(5 Suppl):S97-100. [PubMed ID: 15097940]. https://doi.org/10.1016/j.jaad.2003.07.019.

  • 27.

    Carder KR, Fitzpatrick JE, Weston WL, Morelli JG. Self-healing juvenile cutaneous mucinosis. Pediatr Dermatol. 2003;20(1):35-9. [PubMed ID: 12558844].

  • 28.

    Hershko K, Sagi E, Ingber A. Self-healing juvenile cutaneous mucinosis in an infant. Acta Derm Venereol. 2002;82(2):145-6. [PubMed ID: 12125950].

  • 29.

    Kolodziejczyk B, Gazda A, Hernik E, Szczygielska I, Rutkowska-Sak L, Koprowska ML. Self-healing juvenile cutaneous mucinosis. Reumatologia. 2017;55(1):53-6. [PubMed ID: 28386144]. https://doi.org/10.5114/reum.2017.66689.

  • 30.

    Dolenc-Voljc M, Jurcic V, Hocevar A, Tomsic M. Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin. Case Rep Dermatol. 2013;5(3):309-15. [PubMed ID: 24348379]. https://doi.org/10.1159/000356469.

  • 31.

    Topf S, Simon MJ, Schell H, Luftl M. [Marked improvement in scleromyxedema with high-dose intravenous immunoglobulin]. Hautarzt. 2007;58(6):525-8. [PubMed ID: 17165069]. https://doi.org/10.1007/s00105-006-1261-1.

  • 32.

    Blum M, Wigley FM, Hummers LK. Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore). 2008;87(1):10-20. [PubMed ID: 18204366]. https://doi.org/10.1097/MD.0b013e3181630835.

  • 33.

    Efthimiou P, Blanco M. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature. Semin Arthritis Rheum. 2008;38(3):188-94. [PubMed ID: 18221985]. https://doi.org/10.1016/j.semarthrit.2007.10.015.

  • 34.

    Macnab M, Kenny P. Successful intravenous immunoglobulin treatment of atypical lichen myxedematosus associated with hypothyroidism and central nervous system involvement: case report and discussion of the literature. J Cutan Med Surg. 2013;17(1):69-73. [PubMed ID: 23364155]. https://doi.org/10.2310/7750.2012.11125.

  • 35.

    Sroa N, Campbell S, Bechtel M. Intravenous immunoglobulin therapy for scleromyxedema: a case report and review of literature. J Drugs Dermatol. 2010;9(3):263-5. [PubMed ID: 20232589].